Agenix Limited
Description Agenix Limited operates as a biotechnology company primarily in Australia and the Peoples Republic of China. The company operates through AGX-1009 and ThromboView segments. The AGX-1009 segment focuses on the development of its hepatitis B drug candidate that is a patented novel targeted prodrug analog of an existing compound, Tenofovir, which is in pre-clinical trials. The ThromboView segment focuses on the development of a monoclonal antibody related to the detection of blood clots that has completed two Phase II clinical trials. The company also offers You He Ding, an anti-hepatitis B virus drug; and has a pipeline of anti-viral drugs in pre-clinical development. It has various patents in the United States, Australia, New Zealand, Singapore, and Europe. Agenix Limited is based in Melbourne, Australia. To view the detailed information, you need to SUBSCRIBE with us. |
 |